Ramon Ty
Cardiology · Houston, TXNPI 1861474595
Payments from drug & device makers
Across 444 payments — averaging $24.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Johnson & Johnson$1K
- Amgen$919
- Boehringer Ingelheim$874
- Merck$871
- Boston Scientific$838
- plus $4K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 70 | $2,209 |
| Johnson & Johnson | 71 | $1,339 |
| Amgen | 44 | $919 |
| Boehringer Ingelheim | 36 | $874 |
| Merck | 45 | $871 |
| Boston Scientific | 20 | $838 |
| Abbott | 12 | $726 |
| Novartis | 24 | $435 |
| Lilly USA, LLC | 24 | $374 |
| Novo Nordisk | 21 | $352 |
| Esperion Therapeutics, Inc. | 17 | $271 |
| Impulse Dynamics (USA) Inc. | 2 | $265 |
| Medtronic(2 entities) | 2 | $194 |
| Sanofi-aventis U.S. LLC | 6 | $173 |
| E.r. Squibb & Sons, L.L.C. | 9 | $170 |
| Lexicon Pharmaceuticals, Inc. | 2 | $139 |
| Kowa Pharmaceuticals America, Inc. | 8 | $132 |
| Abiomed | 2 | $130 |
| GSK | 5 | $105 |
| Bayer | 4 | $86 |
| Pfizer | 3 | $81 |
| Baxter Healthcare | 1 | $54 |
| Teva Pharmaceuticals USA, Inc. | 1 | $47 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Agepha Pharma FZ LLC | 2 | $43 |
| Cardiva Medical, Inc. | 1 | $37 |
| Edwards Lifesciences | 1 | $34 |
| Scpharmaceuticals Inc. | 2 | $31 |
| Chiesi USA, Inc. | 2 | $31 |
| Kestra Medical Technology Services, Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $14 |
| AbbVie | 1 | $13 |
How this compares
$11,080 in reported general payments places this provider in the 80th percentile of 33 cardiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiology in Houston
- Sheikh AhmedHouston$14K
- Thieu NguyenHouston$5K
- Nadim ZaccaHouston$2K
- Julian KangHouston$0
- Leroy SterlingHouston$0
- Faizan IftikharMcKinney$1.9M
- Lane MillerCollege Station$37K
- Harvey SluskyWebster$26K
- Shiny MathewkuttyDallas$24K
- Nadir AliWebster$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.